Automated planning of curved needle channels in 3D printed patient-tailored applicators for cervical cancer brachytherapy

Journal Article (2024)
Author(s)

R. Straathof (TU Delft - Medical Instruments & Bio-Inspired Technology, Erasmus MC)

Sharline M. van Vliet-Pérez (TU Delft - Medical Instruments & Bio-Inspired Technology, Erasmus MC)

Inger Karine Kolkman-Deurloo (Erasmus MC)

L. S.G.L. Wauben (TU Delft - Medical Instruments & Bio-Inspired Technology)

Remi Nout (Erasmus MC)

Ben Heijmen (Erasmus MC)

Linda Rossi (Erasmus MC)

J Dankelman (TU Delft - Medical Instruments & Bio-Inspired Technology)

N.J. van de Berg (TU Delft - Medical Instruments & Bio-Inspired Technology, Erasmus MC)

Research Group
Medical Instruments & Bio-Inspired Technology
DOI related publication
https://doi.org/10.1088/1361-6560/ad8b08
More Info
expand_more
Publication Year
2024
Language
English
Research Group
Medical Instruments & Bio-Inspired Technology
Issue number
23
Volume number
69
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Purpose. Patient-tailored intracavitary/interstitial (IC/IS) brachytherapy (BT) applicators may increase dose conformity in cervical cancer patients. Current configuration planning methods in these custom applicators rely on manual specification or a small set of (straight) needles. This work introduces and validates a two-stage approach for establishing channel configurations in the 3D printed patient-tailored ARCHITECT applicator. Methods. For each patient, the patient-tailored applicator shape was based on the first BT application with a commercial applicator and integrated connectors to a commercial (Geneva) intrauterine tube and two lunar ring channels. First, a large candidate set was generated of channels that steer the needle to desired poses in the target region and are contained in the applicator. The channels’ centrelines were represented by Bézier curves. Channels running between straight target segments and entry points were optimised and refined to ensure (dynamic) feasibility. Second, channel configurations were selected using geometric coverage optimisation. This workflow was applied to establish patient-tailored geometries for twenty-two patients previously treated using the Venezia applicator. Treatment plans were automatically generated using the in-house developed algorithm BiCycle. Plans for the clinically used configuration, T P clin , and patient-tailored configuration, T P arch , were compared. Results. Channel configurations could be generated in clinically feasible time (median: 2651 s, range 1826-3812 s). All T P arch and T P clin plans were acceptable, but planning aims were more frequently attained with patient-tailored configurations (115/132 versus 100/132 instances). Median CTVIR D 98 and bladder D 2 c m 3 doses significantly improved ( p < 0.001 and p < 0.01 respectively) in T P arch plans in comparison with T P clin plans, and in approximately half of the patients dosimetric indices improved. Conclusion. Automated patient-tailored BT channel configuration planning for 3D printed applicators is clinically feasible. A treatment planning study showed that all plans met planning limits for the patient-tailored configurations, and in selected cases improved the plan quality in comparison with commercial applicator configurations.